BIOCON
|
The Current P/B Ratio of BIOCON is 2.41.
Share Price | ₹390.2 | Jul 15,2025 |
Market Cap | ₹52,169.7 Cr | |
Book Value | ₹21,644.0 Cr | Mar2025 - Consolidated Results |
Price/Book | 2.41x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of BIOCON
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹52,169.7 Cr] as on Jul 15,2025
(/) Book Value [ ₹21,644.0 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 2.41x ]
Thus, for BIOCON , the investors are currently willing to pay '2.41 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOCON !
The chart below summarizes the trend in P/B Ratio of BIOCON over the last five years.
Historical PB (Price/Book ) ratio chart of BIOCON
PB Ratio Performance Analysis for BIOCON
- BIOCON 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.88x.
- BIOCON 's operated at median p/b ratio of 4.88x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/b ratio peaked in Mar2021 at 6.57x.
- BIOCON 's p/b ratio hit its five-year low in Mar2023 of 1.41x.
How does BIOCON 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
BIOCON | 21,644.00 | 2.41 | 52,169.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.74 | 414,533.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 12.04 | 180,215.0 |
CIPLA LTD | 31,079.30 | 3.87 | 120,428.0 |
TORRENT PHARMACEUTICALS LTD | 7,590.69 | 15.34 | 116,410.0 |
DR REDDYS LABORATORIES LTD | 33,404.90 | 3.15 | 105,253.0 |
MANKIND PHARMA LTD | 14,332.40 | 7.64 | 109,464.0 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.06 | 97,317.9 |
LUPIN LTD | 17,203.50 | 5.18 | 89,121.3 |
AUROBINDO PHARMA LTD | 32,653.30 | 2.05 | 66,911.2 |
ABBOTT INDIA LTD | 4,233.15 | 17.23 | 72,938.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOCON 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.05x |
Max industry PB | 17.23x |
Median industry PB | 5.18x |
Average industry PB | 7.16x |
You may also like the below Video Courses